img

Global Gabapentin Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Gabapentin Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain.
Gabapentin Drug report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Gabapentin Drug market is projected to reach US$ 1985.5 million in 2029, increasing from US$ 1542 million in 2022, with the CAGR of 3.6% during the period of 2024 to 2029. Demand from Postherpetic Neuralgia in Adults and Partial Onset Seizures are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Gabapentin Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Pfizer
Depomed
Apotex
Teva
Acella Pharmaceuticals
Taro
Sun Pharmaceutical
Glenmark
Amneal Pharmaceuticals
Aurobindo Pharma
Zydus Pharmaceuticals
Hi-Tech Pharmaceuticals
Marksans Pharma
Mylan
InvaGen Pharmaceuticals
Alkem Laboratories
Tris Pharma
ACI HealthCare Limited
Jiangsu Hengrui Medicine
CSPC Ouyi Pharmaceutical
Sciegen Pharmaceuticals
Epic Pharma
Lupin Limited
Segment by Type
Capsule
Tablet
Oral Solution

Segment by Application


Postherpetic Neuralgia in Adults
Partial Onset Seizures
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Gabapentin Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Gabapentin Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Gabapentin Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Gabapentin Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Gabapentin Drug introduction, etc. Gabapentin Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports Conclusions of Gabapentin Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Gabapentin Drug Market Overview
1.1 Gabapentin Drug Product Overview
1.2 Gabapentin Drug Market Segment by Type
1.2.1 Capsule
1.2.2 Tablet
1.2.3 Oral Solution
1.3 Global Gabapentin Drug Market Size by Type
1.3.1 Global Gabapentin Drug Market Size Overview by Type (2018-2029)
1.3.2 Global Gabapentin Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Gabapentin Drug Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Gabapentin Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Gabapentin Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Gabapentin Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Gabapentin Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Gabapentin Drug Sales Breakdown by Type (2018-2024)
2 Global Gabapentin Drug Market Competition by Company
2.1 Global Top Players by Gabapentin Drug Sales (2018-2024)
2.2 Global Top Players by Gabapentin Drug Revenue (2018-2024)
2.3 Global Top Players by Gabapentin Drug Price (2018-2024)
2.4 Global Top Manufacturers Gabapentin Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Gabapentin Drug Market Competitive Situation and Trends
2.5.1 Gabapentin Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Gabapentin Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gabapentin Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Gabapentin Drug Market
2.8 Key Manufacturers Gabapentin Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Gabapentin Drug Status and Outlook by Region
3.1 Global Gabapentin Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Gabapentin Drug Historic Market Size by Region
3.2.1 Global Gabapentin Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Gabapentin Drug Sales in Value by Region (2018-2024)
3.2.3 Global Gabapentin Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Gabapentin Drug Forecasted Market Size by Region
3.3.1 Global Gabapentin Drug Sales in Volume by Region (2024-2029)
3.3.2 Global Gabapentin Drug Sales in Value by Region (2024-2029)
3.3.3 Global Gabapentin Drug Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Gabapentin Drug by Application
4.1 Gabapentin Drug Market Segment by Application
4.1.1 Postherpetic Neuralgia in Adults
4.1.2 Partial Onset Seizures
4.1.3 Others
4.2 Global Gabapentin Drug Market Size by Application
4.2.1 Global Gabapentin Drug Market Size Overview by Application (2018-2029)
4.2.2 Global Gabapentin Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Gabapentin Drug Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Gabapentin Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Gabapentin Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Gabapentin Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Gabapentin Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Gabapentin Drug Sales Breakdown by Application (2018-2024)
5 North America Gabapentin Drug by Country
5.1 North America Gabapentin Drug Historic Market Size by Country
5.1.1 North America Gabapentin Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Gabapentin Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Gabapentin Drug Sales in Value by Country (2018-2024)
5.2 North America Gabapentin Drug Forecasted Market Size by Country
5.2.1 North America Gabapentin Drug Sales in Volume by Country (2024-2029)
5.2.2 North America Gabapentin Drug Sales in Value by Country (2024-2029)
6 Europe Gabapentin Drug by Country
6.1 Europe Gabapentin Drug Historic Market Size by Country
6.1.1 Europe Gabapentin Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Gabapentin Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Gabapentin Drug Sales in Value by Country (2018-2024)
6.2 Europe Gabapentin Drug Forecasted Market Size by Country
6.2.1 Europe Gabapentin Drug Sales in Volume by Country (2024-2029)
6.2.2 Europe Gabapentin Drug Sales in Value by Country (2024-2029)
7 Asia-Pacific Gabapentin Drug by Region
7.1 Asia-Pacific Gabapentin Drug Historic Market Size by Region
7.1.1 Asia-Pacific Gabapentin Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Gabapentin Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Gabapentin Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Gabapentin Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Gabapentin Drug Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Gabapentin Drug Sales in Value by Region (2024-2029)
8 Latin America Gabapentin Drug by Country
8.1 Latin America Gabapentin Drug Historic Market Size by Country
8.1.1 Latin America Gabapentin Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Gabapentin Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Gabapentin Drug Sales in Value by Country (2018-2024)
8.2 Latin America Gabapentin Drug Forecasted Market Size by Country
8.2.1 Latin America Gabapentin Drug Sales in Volume by Country (2024-2029)
8.2.2 Latin America Gabapentin Drug Sales in Value by Country (2024-2029)
9 Middle East and Africa Gabapentin Drug by Country
9.1 Middle East and Africa Gabapentin Drug Historic Market Size by Country
9.1.1 Middle East and Africa Gabapentin Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Gabapentin Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Gabapentin Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Gabapentin Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Gabapentin Drug Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Gabapentin Drug Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Gabapentin Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Pfizer Gabapentin Drug Products Offered
10.1.5 Pfizer Recent Development
10.2 Depomed
10.2.1 Depomed Company Information
10.2.2 Depomed Introduction and Business Overview
10.2.3 Depomed Gabapentin Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Depomed Gabapentin Drug Products Offered
10.2.5 Depomed Recent Development
10.3 Apotex
10.3.1 Apotex Company Information
10.3.2 Apotex Introduction and Business Overview
10.3.3 Apotex Gabapentin Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Apotex Gabapentin Drug Products Offered
10.3.5 Apotex Recent Development
10.4 Teva
10.4.1 Teva Company Information
10.4.2 Teva Introduction and Business Overview
10.4.3 Teva Gabapentin Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Teva Gabapentin Drug Products Offered
10.4.5 Teva Recent Development
10.5 Acella Pharmaceuticals
10.5.1 Acella Pharmaceuticals Company Information
10.5.2 Acella Pharmaceuticals Introduction and Business Overview
10.5.3 Acella Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Acella Pharmaceuticals Gabapentin Drug Products Offered
10.5.5 Acella Pharmaceuticals Recent Development
10.6 Taro
10.6.1 Taro Company Information
10.6.2 Taro Introduction and Business Overview
10.6.3 Taro Gabapentin Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Taro Gabapentin Drug Products Offered
10.6.5 Taro Recent Development
10.7 Sun Pharmaceutical
10.7.1 Sun Pharmaceutical Company Information
10.7.2 Sun Pharmaceutical Introduction and Business Overview
10.7.3 Sun Pharmaceutical Gabapentin Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Sun Pharmaceutical Gabapentin Drug Products Offered
10.7.5 Sun Pharmaceutical Recent Development
10.8 Glenmark
10.8.1 Glenmark Company Information
10.8.2 Glenmark Introduction and Business Overview
10.8.3 Glenmark Gabapentin Drug Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Glenmark Gabapentin Drug Products Offered
10.8.5 Glenmark Recent Development
10.9 Amneal Pharmaceuticals
10.9.1 Amneal Pharmaceuticals Company Information
10.9.2 Amneal Pharmaceuticals Introduction and Business Overview
10.9.3 Amneal Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Amneal Pharmaceuticals Gabapentin Drug Products Offered
10.9.5 Amneal Pharmaceuticals Recent Development
10.10 Aurobindo Pharma
10.10.1 Aurobindo Pharma Company Information
10.10.2 Aurobindo Pharma Introduction and Business Overview
10.10.3 Aurobindo Pharma Gabapentin Drug Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Aurobindo Pharma Gabapentin Drug Products Offered
10.10.5 Aurobindo Pharma Recent Development
10.11 Zydus Pharmaceuticals
10.11.1 Zydus Pharmaceuticals Company Information
10.11.2 Zydus Pharmaceuticals Introduction and Business Overview
10.11.3 Zydus Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Zydus Pharmaceuticals Gabapentin Drug Products Offered
10.11.5 Zydus Pharmaceuticals Recent Development
10.12 Hi-Tech Pharmaceuticals
10.12.1 Hi-Tech Pharmaceuticals Company Information
10.12.2 Hi-Tech Pharmaceuticals Introduction and Business Overview
10.12.3 Hi-Tech Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Hi-Tech Pharmaceuticals Gabapentin Drug Products Offered
10.12.5 Hi-Tech Pharmaceuticals Recent Development
10.13 Marksans Pharma
10.13.1 Marksans Pharma Company Information
10.13.2 Marksans Pharma Introduction and Business Overview
10.13.3 Marksans Pharma Gabapentin Drug Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Marksans Pharma Gabapentin Drug Products Offered
10.13.5 Marksans Pharma Recent Development
10.14 Mylan
10.14.1 Mylan Company Information
10.14.2 Mylan Introduction and Business Overview
10.14.3 Mylan Gabapentin Drug Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Mylan Gabapentin Drug Products Offered
10.14.5 Mylan Recent Development
10.15 InvaGen Pharmaceuticals
10.15.1 InvaGen Pharmaceuticals Company Information
10.15.2 InvaGen Pharmaceuticals Introduction and Business Overview
10.15.3 InvaGen Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2018-2024)
10.15.4 InvaGen Pharmaceuticals Gabapentin Drug Products Offered
10.15.5 InvaGen Pharmaceuticals Recent Development
10.16 Alkem Laboratories
10.16.1 Alkem Laboratories Company Information
10.16.2 Alkem Laboratories Introduction and Business Overview
10.16.3 Alkem Laboratories Gabapentin Drug Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Alkem Laboratories Gabapentin Drug Products Offered
10.16.5 Alkem Laboratories Recent Development
10.17 Tris Pharma
10.17.1 Tris Pharma Company Information
10.17.2 Tris Pharma Introduction and Business Overview
10.17.3 Tris Pharma Gabapentin Drug Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Tris Pharma Gabapentin Drug Products Offered
10.17.5 Tris Pharma Recent Development
10.18 ACI HealthCare Limited
10.18.1 ACI HealthCare Limited Company Information
10.18.2 ACI HealthCare Limited Introduction and Business Overview
10.18.3 ACI HealthCare Limited Gabapentin Drug Sales, Revenue and Gross Margin (2018-2024)
10.18.4 ACI HealthCare Limited Gabapentin Drug Products Offered
10.18.5 ACI HealthCare Limited Recent Development
10.19 Jiangsu Hengrui Medicine
10.19.1 Jiangsu Hengrui Medicine Company Information
10.19.2 Jiangsu Hengrui Medicine Introduction and Business Overview
10.19.3 Jiangsu Hengrui Medicine Gabapentin Drug Sales, Revenue and Gross Margin (2018-2024)
10.19.4 Jiangsu Hengrui Medicine Gabapentin Drug Products Offered
10.19.5 Jiangsu Hengrui Medicine Recent Development
10.20 CSPC Ouyi Pharmaceutical
10.20.1 CSPC Ouyi Pharmaceutical Company Information
10.20.2 CSPC Ouyi Pharmaceutical Introduction and Business Overview
10.20.3 CSPC Ouyi Pharmaceutical Gabapentin Drug Sales, Revenue and Gross Margin (2018-2024)
10.20.4 CSPC Ouyi Pharmaceutical Gabapentin Drug Products Offered
10.20.5 CSPC Ouyi Pharmaceutical Recent Development
10.21 Sciegen Pharmaceuticals
10.21.1 Sciegen Pharmaceuticals Company Information
10.21.2 Sciegen Pharmaceuticals Introduction and Business Overview
10.21.3 Sciegen Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2018-2024)
10.21.4 Sciegen Pharmaceuticals Gabapentin Drug Products Offered
10.21.5 Sciegen Pharmaceuticals Recent Development
10.22 Epic Pharma
10.22.1 Epic Pharma Company Information
10.22.2 Epic Pharma Introduction and Business Overview
10.22.3 Epic Pharma Gabapentin Drug Sales, Revenue and Gross Margin (2018-2024)
10.22.4 Epic Pharma Gabapentin Drug Products Offered
10.22.5 Epic Pharma Recent Development
10.23 Lupin Limited
10.23.1 Lupin Limited Company Information
10.23.2 Lupin Limited Introduction and Business Overview
10.23.3 Lupin Limited Gabapentin Drug Sales, Revenue and Gross Margin (2018-2024)
10.23.4 Lupin Limited Gabapentin Drug Products Offered
10.23.5 Lupin Limited Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Gabapentin Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Gabapentin Drug Industrial Chain Analysis
11.4 Gabapentin Drug Market Dynamics
11.4.1 Gabapentin Drug Industry Trends
11.4.2 Gabapentin Drug Market Drivers
11.4.3 Gabapentin Drug Market Challenges
11.4.4 Gabapentin Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Gabapentin Drug Distributors
12.3 Gabapentin Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Capsule
Table 2. Major Company of Tablet
Table 3. Major Company of Oral Solution
Table 4. Global Gabapentin Drug Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Gabapentin Drug Sales by Type (2018-2024) & (K Units)
Table 6. Global Gabapentin Drug Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Gabapentin Drug Sales by Type (2018-2024) & (US& Million)
Table 8. Global Gabapentin Drug Market Share in Value by Type (2018-2024)
Table 9. Global Gabapentin Drug Price by Type (2018-2024) & (USD/Unit)
Table 10. Global Gabapentin Drug Sales by Type (2024-2029) & (K Units)
Table 11. Global Gabapentin Drug Sales Market Share in Volume by Type (2024-2029)
Table 12. Global Gabapentin Drug Sales by Type (2024-2029) & (US$ Million)
Table 13. Global Gabapentin Drug Sales Market Share in Value by Type (2024-2029)
Table 14. Global Gabapentin Drug Price by Type (2024-2029) & (USD/Unit)
Table 15. North America Gabapentin Drug Sales by Type (2018-2024) & (K Units)
Table 16. North America Gabapentin Drug Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Gabapentin Drug Sales (K Units) by Type (2018-2024)
Table 18. Europe Gabapentin Drug Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Gabapentin Drug Sales (K Units) by Type (2018-2024)
Table 20. Asia-Pacific Gabapentin Drug Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Gabapentin Drug Sales (K Units) by Type (2018-2024)
Table 22. Latin America Gabapentin Drug Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Gabapentin Drug Sales (K Units) by Type (2018-2024)
Table 24. Middle East and Africa Gabapentin Drug Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Gabapentin Drug Sales by Company (2018-2024) & (K Units)
Table 26. Global Gabapentin Drug Sales Share by Company (2018-2024)
Table 27. Global Gabapentin Drug Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Gabapentin Drug Revenue Share by Company (2018-2024)
Table 29. Global Market Gabapentin Drug Price by Company (2018-2024) & (USD/Unit)
Table 30. Global Gabapentin Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Gabapentin Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gabapentin Drug as of 2022)
Table 33. Date of Key Manufacturers Enter into Gabapentin Drug Market
Table 34. Key Manufacturers Gabapentin Drug Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Gabapentin Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 37. Global Gabapentin Drug Sales by Region (2018-2024) & (K Units)
Table 38. Global Gabapentin Drug Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Gabapentin Drug Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Gabapentin Drug Sales Market Share in Value by Region (2018-2024)
Table 41. Global Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 42. Global Gabapentin Drug Sales by Region (2024-2029) & (K Units)
Table 43. Global Gabapentin Drug Sales Market Share in Volume by Region (2024-2029)
Table 44. Global Gabapentin Drug Sales by Region (2024-2029) & (US$ Million)
Table 45. Global Gabapentin Drug Sales Market Share in Value by Region (2024-2029)
Table 46. Global Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2029)
Table 47. Global Gabapentin Drug Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 48. Global Gabapentin Drug Sales by Application (2018-2024) & (K Units)
Table 49. Global Gabapentin Drug Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Gabapentin Drug Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Gabapentin Drug Sales Market Share in Value by Application (2018-2024)
Table 52. Global Gabapentin Drug Price by Application (2018-2024) & (USD/Unit)
Table 53. Global Gabapentin Drug Sales by Application (2024-2029) & (K Units)
Table 54. Global Gabapentin Drug Sales Market Share in Volume by Application (2024-2029)
Table 55. Global Gabapentin Drug Sales by Application (2024-2029) & (US$ Million)
Table 56. Global Gabapentin Drug Sales Market Share in Value by Application (2024-2029)
Table 57. Global Gabapentin Drug Price by Application (2024-2029) & (USD/Unit)
Table 58. North America Gabapentin Drug Sales by Application (2018-2024) (K Units)
Table 59. North America Gabapentin Drug Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Gabapentin Drug Sales by Application (2018-2024) (K Units)
Table 61. Europe Gabapentin Drug Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Gabapentin Drug Sales by Application (2018-2024) (K Units)
Table 63. Asia-Pacific Gabapentin Drug Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Gabapentin Drug Sales by Application (2018-2024) (K Units)
Table 65. Latin America Gabapentin Drug Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Gabapentin Drug Sales by Application (2018-2024) (K Units)
Table 67. Middle East and Africa Gabapentin Drug Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Gabapentin Drug Sales by Country (2018-2024) & (K Units)
Table 69. North America Gabapentin Drug Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Gabapentin Drug Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Gabapentin Drug Sales Market Share in Value by Country (2018-2024)
Table 72. North America Gabapentin Drug Sales by Country (2024-2029) & (K Units)
Table 73. North America Gabapentin Drug Sales Market Share in Volume by Country (2024-2029)
Table 74. North America Gabapentin Drug Sales by Country (2024-2029) & (US$ Million)
Table 75. North America Gabapentin Drug Sales Market Share in Value by Country (2024-2029)
Table 76. Europe Gabapentin Drug Sales by Country (2018-2024) & (K Units)
Table 77. Europe Gabapentin Drug Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Gabapentin Drug Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Gabapentin Drug Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Gabapentin Drug Sales by Country (2024-2029) & (K Units)
Table 81. Europe Gabapentin Drug Sales Market Share in Volume by Country (2024-2029)
Table 82. Europe Gabapentin Drug Sales by Country (2024-2029) & (US$ Million)
Table 83. Europe Gabapentin Drug Sales Market Share in Value by Country (2024-2029)
Table 84. Asia-Pacific Gabapentin Drug Sales by Region (2018-2024) & (K Units)
Table 85. Asia-Pacific Gabapentin Drug Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Gabapentin Drug Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Gabapentin Drug Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Gabapentin Drug Sales by Region (2024-2029) & (K Units)
Table 89. Asia-Pacific Gabapentin Drug Sales Market Share in Volume by Region (2024-2029)
Table 90. Asia-Pacific Gabapentin Drug Sales by Region (2024-2029) & (US$ Million)
Table 91. Asia-Pacific Gabapentin Drug Sales Market Share in Value by Region (2024-2029)
Table 92. Latin America Gabapentin Drug Sales by Country (2018-2024) & (K Units)
Table 93. Latin America Gabapentin Drug Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Gabapentin Drug Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Gabapentin Drug Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Gabapentin Drug Sales by Country (2024-2029) & (K Units)
Table 97. Latin America Gabapentin Drug Sales Market Share in Volume by Country (2024-2029)
Table 98. Latin America Gabapentin Drug Sales by Country (2024-2029) & (US$ Million)
Table 99. Latin America Gabapentin Drug Sales Market Share in Value by Country (2024-2029)
Table 100. Middle East and Africa Gabapentin Drug Sales by Country (2018-2024) & (K Units)
Table 101. Middle East and Africa Gabapentin Drug Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Gabapentin Drug Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Gabapentin Drug Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Gabapentin Drug Sales by Country (2024-2029) & (K Units)
Table 105. Middle East and Africa Gabapentin Drug Sales Market Share in Volume by Country (2024-2029)
Table 106. Middle East and Africa Gabapentin Drug Sales by Country (2024-2029) & (US$ Million)
Table 107. Middle East and Africa Gabapentin Drug Sales Market Share in Value by Country (2024-2029)
Table 108. Pfizer Company Information
Table 109. Pfizer Introduction and Business Overview
Table 110. Pfizer Gabapentin Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 111. Pfizer Gabapentin Drug Product
Table 112. Pfizer Recent Development
Table 113. Depomed Company Information
Table 114. Depomed Introduction and Business Overview
Table 115. Depomed Gabapentin Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 116. Depomed Gabapentin Drug Product
Table 117. Depomed Recent Development
Table 118. Apotex Company Information
Table 119. Apotex Introduction and Business Overview
Table 120. Apotex Gabapentin Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 121. Apotex Gabapentin Drug Product
Table 122. Apotex Recent Development
Table 123. Teva Company Information
Table 124. Teva Introduction and Business Overview
Table 125. Teva Gabapentin Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 126. Teva Gabapentin Drug Product
Table 127. Teva Recent Development
Table 128. Acella Pharmaceuticals Company Information
Table 129. Acella Pharmaceuticals Introduction and Business Overview
Table 130. Acella Pharmaceuticals Gabapentin Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 131. Acella Pharmaceuticals Gabapentin Drug Product
Table 132. Acella Pharmaceuticals Recent Development
Table 133. Taro Company Information
Table 134. Taro Introduction and Business Overview
Table 135. Taro Gabapentin Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 136. Taro Gabapentin Drug Product
Table 137. Taro Recent Development
Table 138. Sun Pharmaceutical Company Information
Table 139. Sun Pharmaceutical Introduction and Business Overview
Table 140. Sun Pharmaceutical Gabapentin Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 141. Sun Pharmaceutical Gabapentin Drug Product
Table 142. Sun Pharmaceutical Recent Development
Table 143. Glenmark Company Information
Table 144. Glenmark Introduction and Business Overview
Table 145. Glenmark Gabapentin Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 146. Glenmark Gabapentin Drug Product
Table 147. Glenmark Recent Development
Table 148. Amneal Pharmaceuticals Company Information
Table 149. Amneal Pharmaceuticals Introduction and Business Overview
Table 150. Amneal Pharmaceuticals Gabapentin Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 151. Amneal Pharmaceuticals Gabapentin Drug Product
Table 152. Amneal Pharmaceuticals Recent Development
Table 153. Aurobindo Pharma Company Information
Table 154. Aurobindo Pharma Introduction and Business Overview
Table 155. Aurobindo Pharma Gabapentin Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 156. Aurobindo Pharma Gabapentin Drug Product
Table 157. Aurobindo Pharma Recent Development
Table 158. Zydus Pharmaceuticals Company Information
Table 159. Zydus Pharmaceuticals Introduction and Business Overview
Table 160. Zydus Pharmaceuticals Gabapentin Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 161. Zydus Pharmaceuticals Gabapentin Drug Product
Table 162. Zydus Pharmaceuticals Recent Development
Table 163. Hi-Tech Pharmaceuticals Company Information
Table 164. Hi-Tech Pharmaceuticals Introduction and Business Overview
Table 165. Hi-Tech Pharmaceuticals Gabapentin Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 166. Hi-Tech Pharmaceuticals Gabapentin Drug Product
Table 167. Hi-Tech Pharmaceuticals Recent Development
Table 168. Marksans Pharma Company Information
Table 169. Marksans Pharma Introduction and Business Overview
Table 170. Marksans Pharma Gabapentin Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 171. Marksans Pharma Gabapentin Drug Product
Table 172. Marksans Pharma Recent Development
Table 173. Mylan Company Information
Table 174. Mylan Introduction and Business Overview
Table 175. Mylan Gabapentin Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 176. Mylan Gabapentin Drug Product
Table 177. Mylan Recent Development
Table 178. InvaGen Pharmaceuticals Company Information
Table 179. InvaGen Pharmaceuticals Introduction and Business Overview
Table 180. InvaGen Pharmaceuticals Gabapentin Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 181. InvaGen Pharmaceuticals Gabapentin Drug Product
Table 182. InvaGen Pharmaceuticals Recent Development
Table 183. Alkem Laboratories Company Information
Table 184. Alkem Laboratories Introduction and Business Overview
Table 185. Alkem Laboratories Gabapentin Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 186. Alkem Laboratories Gabapentin Drug Product
Table 187. Alkem Laboratories Recent Development
Table 188. Tris Pharma Company Information
Table 189. Tris Pharma Introduction and Business Overview
Table 190. Tris Pharma Gabapentin Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 191. Tris Pharma Gabapentin Drug Product
Table 192. Tris Pharma Recent Development
Table 193. ACI HealthCare Limited Company Information
Table 194. ACI HealthCare Limited Introduction and Business Overview
Table 195. ACI HealthCare Limited Gabapentin Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 196. ACI HealthCare Limited Gabapentin Drug Product
Table 197. ACI HealthCare Limited Recent Development
Table 198. Jiangsu Hengrui Medicine Company Information
Table 199. Jiangsu Hengrui Medicine Introduction and Business Overview
Table 200. Jiangsu Hengrui Medicine Gabapentin Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 201. Jiangsu Hengrui Medicine Gabapentin Drug Product
Table 202. Jiangsu Hengrui Medicine Recent Development
Table 203. CSPC Ouyi Pharmaceutical Company Information
Table 204. CSPC Ouyi Pharmaceutical Introduction and Business Overview
Table 205. CSPC Ouyi Pharmaceutical Gabapentin Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 206. CSPC Ouyi Pharmaceutical Gabapentin Drug Product
Table 207. CSPC Ouyi Pharmaceutical Recent Development
Table 208. Sciegen Pharmaceuticals Company Information
Table 209. Sciegen Pharmaceuticals Introduction and Business Overview
Table 210. Sciegen Pharmaceuticals Gabapentin Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 211. Sciegen Pharmaceuticals Gabapentin Drug Product
Table 212. Sciegen Pharmaceuticals Recent Development
Table 213. Epic Pharma Company Information
Table 214. Epic Pharma Introduction and Business Overview
Table 215. Epic Pharma Gabapentin Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 216. Epic Pharma Gabapentin Drug Product
Table 217. Epic Pharma Recent Development
Table 218. Lupin Limited Company Information
Table 219. Lupin Limited Introduction and Business Overview
Table 220. Lupin Limited Gabapentin Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 221. Lupin Limited Gabapentin Drug Product
Table 222. Lupin Limited Recent Development
Table 223. Key Raw Materials Lists
Table 224. Raw Materials Key Suppliers Lists
Table 225. Gabapentin Drug Market Trends
Table 226. Gabapentin Drug Market Drivers
Table 227. Gabapentin Drug Market Challenges
Table 228. Gabapentin Drug Market Restraints
Table 229. Gabapentin Drug Distributors List
Table 230. Gabapentin Drug Downstream Customers
Table 231. Research Programs/Design for This Report
Table 232. Key Data Information from Secondary Sources
Table 233. Key Data Information from Primary Sources
List of Figures
Figure 1. Gabapentin Drug Product Picture
Figure 2. Global Gabapentin Drug Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Gabapentin Drug Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Gabapentin Drug Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Capsule
Figure 6. Global Capsule Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Tablet
Figure 8. Global Tablet Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of Oral Solution
Figure 10. Global Oral Solution Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Global Gabapentin Drug Sales by Type (2018-2029) & (US$ Million)
Figure 12. Global Gabapentin Drug Sales Market Share by Type in 2022 & 2029
Figure 13. North America Gabapentin Drug Sales Market Share in Volume by Type in 2022
Figure 14. North America Gabapentin Drug Sales Market Share in Value by Type in 2022
Figure 15. Europe Gabapentin Drug Sales Market Share in Volume by Type in 2022
Figure 16. Europe Gabapentin Drug Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Gabapentin Drug Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Gabapentin Drug Sales Market Share in Value by Type in 2022
Figure 19. Latin America Gabapentin Drug Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Gabapentin Drug Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Gabapentin Drug Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Gabapentin Drug Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Gabapentin Drug Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Gabapentin Drug Revenue in 2022
Figure 25. Gabapentin Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Postherpetic Neuralgia in Adults
Figure 27. Global Postherpetic Neuralgia in Adults Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Product Picture of Partial Onset Seizures
Figure 29. Global Partial Onset Seizures Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Others
Figure 31. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Global Gabapentin Drug Sales by Application (2018-2029) & (US$ Million)
Figure 33. Global Gabapentin Drug Sales Market Share by Application in 2022 & 2029
Figure 34. North America Gabapentin Drug Sales Market Share in Volume by Application in 2022
Figure 35. North America Gabapentin Drug Sales Market Share in Value by Application in 2022
Figure 36. Europe Gabapentin Drug Sales Market Share in Volume by Application in 2022
Figure 37. Europe Gabapentin Drug Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Gabapentin Drug Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Gabapentin Drug Sales Market Share in Value by Application in 2022
Figure 40. Latin America Gabapentin Drug Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Gabapentin Drug Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Gabapentin Drug Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Gabapentin Drug Manufacturing Cost Structure
Figure 45. Gabapentin Drug Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries